DeveloGen Diabetes Pax4 Gene Therapy Enters Late Preclinicals
A gene therapy approach to treat diabetes has passed through several validation screens and is now being tested in higher mammals including primates, DeveloGen VP-Corporate Affairs Edward Stuart, PhD, told the Ernst & Young/Atlas Venture European Life Sciences Conference April 17 in Amsterdam.
You may also be interested in...
Cologne, Germany-based genomics firm Artemis' initial $8.8 mil. (DM 15 mil.) round of financing will be used to help develop a "comprehensive technology package" with minority shareholder Exelixis of San Francisco, Calif.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials